Pulmonary Disease, Chronic Obstructive (COPD)NCT07177976
Comparative Effects of Pilates Breathing and Pursed Lip Breathing on Chest Expension and Peak Expiratory Flow Rate in Patients With Chronic Obstructive Lung Disease
A study testing Pilates Breathing Technique along with standard pharmacological management and Pursed-lip breathing along with pharmacological management in people with Pulmonary Disease, Chronic Obstructive (COPD), run by Foundation University Islamabad at 1 site in Pakistan.
Trial summary
Chronic Obstructive Pulmonary Disease is a particular type of irreversible disease that may damage or obstruct airways and make it difficult to breath. This respiratiry condition may lead to shallow breathing. Breathing exercisers help to manage hyperventilation often seen in COPD patients. Read more about this study
- Who is it for?
- Ages 40 to 64 years
- Conditions the study is for
- Pulmonary Disease, Chronic Obstructive (COPD)
- What is being tested?
- Pilates Breathing Technique along with standard pharmacological management and Pursed-lip breathing along with pharmacological management
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 46 participants
- Where
- 1 sitePakistan
- Study dates
- 15 Sep 2025to 1 Feb 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 40 to 64 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- Age between 40-64 years
- Both genders (male and female)
- Grade 1-3 on mMRC scale of dyspnea
- COPD mild stage according to global initiative for chronic obstructive lung disease (GOLD) classification; Mild = FEV1 greater than or equal to 80% predicted
Who cannot join
- Moderate, severe and very severe stage of COPD according to GOLD classification
- Patients having acute exerbation of COPD
- Patients diagnosed with acute infection
- Patients unable to follow command and instructions
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Pakistan1 site, 1 recruiting
- Recruiting
Foundation University College of Physical Therapy, Islamabad, 44000
Rawalpindi, 46000
About this study
Chronic Obstructive Pulmonary Disease is a particular type of irreversible disease that may damage or obstruct airways and make it difficult to breath. This respiratiry condition may lead to shallow breathing.
Breathing exercisers help to manage hyperventilation often seen in COPD patients. To handle respiratory complications patients are advised to practice breathing techniques along with pharmacological management
Read the detailed description
Chronic Obstructive pulmonary Disease is a particular type of irreversible disease that may damage or obstruct airways and make it difficult to breath. This respiratory condition may lead to shallow breathing.
Breathing exercises help to manage hyperventilation often seen in copd patients. To handle respiratory complications patients are advised to practice brathing techniques along with pharmacological management.
Total 46 participants are allocated divided into two group. Group A will perform Pilates breathing along with pharmacological management and group B will perform Pursed-lip breathing along with pharmacological management.
Hence objective of study is to compare the effects of pilates breathing techniques along with pharmacological management versus pursed-lip breathing along with pharmacological management on chest expansion, peak expiratory flow rate, dyspnea and quality of life in patients with chronic obstructive lung disease
- Being tested
- Pilates Breathing Technique along with standard pharmacological management, Pursed-lip breathing along with pharmacological management
- Keywords
- Chest expansion, peak expiratory flow rate, dyspnea
- Medical subject headings
- Lung Diseases, Pulmonary Disease, Chronic Obstructive, Dyspnea
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Pilates Breathing Technique along with standard pharmacological managementProcedure or surgery
Patients in this group will receive pilates breathing technique along with pharmacological management.
A total 3 weeks protocol will be followed in which 2 seesions per week will be supervised by physiotherapist and 5 days at home.
Pilates breathing will be performed in sitting or supine position. The patient will place a hand over the Lower Posterior rib Cage and inhale through the nose.
While breathing they will actively contract the Transverse Abdominis (TrA) as if preparing for punch or holding in urine and engaging the pelvic floor muscles.
Pursed-lip breathing along with pharmacological managementProcedure or surgery
Patient in this group will receive pursed-lip breathing along with pharmacological management. A total 3 weeks protocol will be followed in which 2 sessions per week will be supervised by physiotherapist and 5 days at home.
The patient will sit comfortably with straight back and relaxed shoulders. They will inhale slowly through the nose, with a deep relaxed breath, and then exhale slowly through the pursed lips, as if blowing out a candle. The exhalation should take 2-3 times longer than inhalation. This breathing cycle will be repeated with a focus on slow and relaxed breathing.
Pharmacological management: Patient will receive medications as per prescribed by pulmonologist
| Study group | Role | What they receive |
|---|---|---|
| Group A | Experimental | Patients in this group will receive Pilates breathing techniques along with pharmacological management for total of 3 weeks.
Two sessions per week will be supervised by physiotherapist and 5 days at home. A home diary will be provided in order to ensure and follow-up of the participants are performing breathing exercises at home. Receives: Procedure: Pilates Breathing Technique along with standard pharmacological management |
| Group B | Experimental | Patients in this group will receive Pursed-lip breathing along with pharmacological management for 3 weeks.
Two sessions per weeek will be supervised by physiotherapist and 5 days at home.
A home diary will be provided in order to ensure and follow-up of the participants that they are performing breathing exercises at home. Receives: Procedure: Pursed-lip breathing along with pharmacological management |
What is being measured
The primary outcome is the main question the study is designed to answer.
Chest Expansion
Evaluation will be done using inch tape (inches) for Chest Expansion
Measured: 03 weeks
Peak expiratory flow rate
Evaluation will be done by using Peak flow meter
Measured: 03 weeks
Dyspnea
Evaluation will be done by using Modified Medical Research Council Dyspnea Scale (mMRC)
Measured: 03 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted17 Sep 2025
- Study start15 Sep 2025
- Primary completion1 Jan 2026 (estimated)
- Study completion1 Feb 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Pulmonary Disease, Chronic Obstructive (COPD)Studies of the same condition, open and under way.
- More trials run by Foundation University IslamabadThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- This is a randomized controlled trial having two groups. One group (interventional group) wil receive Pilates breathing along with pharmacological management and the other group (control group) will perform Pursed-lip breathing along with pharmacological management.
- Masking
- None (open label)
- Enrolment
- 46 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Foundation University Islamabad
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07177976
- Sponsor's protocol ID
- FUI/CTR/2025/91
- Status last verified
- Sep 2025
- First submitted
- 10 Sep 2025
- Last updated
- 7 Oct 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 7 Oct 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Comparative Effects of Pilates Breathing and Pursed Lip Breathing on Chest Expension and Peak Expiratory Flow Rate in Patients With Chronic Obstructive Lung Disease
- ClinicalTrials.gov ID
- NCT07177976
- Acronym / sponsor ID
- FUI/CTR/2025/91
- Keywords
- Chest expansion, peak expiratory flow rate, dyspnea
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 46 participants (estimated)
- Lead sponsor
- Foundation University IslamabadUniversity, hospital or other
- Study start
- 15 Sep 2025 (actual)
- Primary completion
- 1 Jan 2026 (estimated)
- Study completion
- 1 Feb 2026 (estimated)
- First posted
- 17 Sep 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Chronic Obstructive Pulmonary Disease is a particular type of irreversible disease that may damage or obstruct airways and make it difficult to breath. This respiratiry condition may lead to shallow breathing.
Breathing exercisers help to manage hyperventilation often seen in COPD patients. To handle respiratory complications patients are advised to practice breathing techniques along with pharmacological management
Detailed description
Chronic Obstructive pulmonary Disease is a particular type of irreversible disease that may damage or obstruct airways and make it difficult to breath. This respiratory condition may lead to shallow breathing.
Breathing exercises help to manage hyperventilation often seen in copd patients. To handle respiratory complications patients are advised to practice brathing techniques along with pharmacological management.
Total 46 participants are allocated divided into two group. Group A will perform Pilates breathing along with pharmacological management and group B will perform Pursed-lip breathing along with pharmacological management.
Hence objective of study is to compare the effects of pilates breathing techniques along with pharmacological management versus pursed-lip breathing along with pharmacological management on chest expansion, peak expiratory flow rate, dyspnea and quality of life in patients with chronic obstructive lung disease
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- This is a randomized controlled trial having two groups. One group (interventional group) wil receive Pilates breathing along with pharmacological management and the other group (control group) will perform Pursed-lip breathing along with pharmacological management.
| Arm | Type | Receives |
|---|---|---|
| Group A | Experimental | Procedure: Pilates Breathing Technique along with standard pharmacological managementPatients in this group will receive Pilates breathing techniques along with pharmacological management for total of 3 weeks. Two sessions per week will be supervised by physiotherapist and 5 days at home. A home diary will be provided in order to ensure and follow-up of the participants are performing breathing exercises at home. |
| Group B | Experimental | Procedure: Pursed-lip breathing along with pharmacological managementPatients in this group will receive Pursed-lip breathing along with pharmacological management for 3 weeks. Two sessions per weeek will be supervised by physiotherapist and 5 days at home. A home diary will be provided in order to ensure and follow-up of the participants that they are performing breathing exercises at home. |
Who may qualify
- Ages
- 40 to 64 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (4 listed)
- Age between 40-64 years
- Both genders (male and female)
- Grade 1-3 on mMRC scale of dyspnea
- COPD mild stage according to global initiative for chronic obstructive lung disease (GOLD) classification; Mild = FEV1 greater than or equal to 80% predicted
Key exclusion criteria (4 listed)
- Moderate, severe and very severe stage of COPD according to GOLD classification
- Patients having acute exerbation of COPD
- Patients diagnosed with acute infection
- Patients unable to follow command and instructions
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Pilates Breathing Technique along with standard pharmacological managementPatients in this group will receive pilates breathing technique along with pharmacological management. A total 3 weeks protocol will be followed in which 2 seesions per week will be supervised by physiotherapist and 5 days at home. Pilates breathing will be performed in sitting or supine position. The patient will place a hand over the Lower Posterior rib Cage and inhale through the nose. While breathing they will actively contract the Transverse Abdominis (TrA) as if preparing for punch or holding in urine and engaging the pelvic floor muscles. | Procedure or surgery | Group A |
| Pursed-lip breathing along with pharmacological managementPatient in this group will receive pursed-lip breathing along with pharmacological management. A total 3 weeks protocol will be followed in which 2 sessions per week will be supervised by physiotherapist and 5 days at home. The patient will sit comfortably with straight back and relaxed shoulders. They will inhale slowly through the nose, with a deep relaxed breath, and then exhale slowly through the pursed lips, as if blowing out a candle. The exhalation should take 2-3 times longer than inhalation. This breathing cycle will be repeated with a focus on slow and relaxed breathing. Pharmacological management: Patient will receive medications as per prescribed by pulmonologist | Procedure or surgery | Group B |
Primary outcome
Chest Expansion
Time frame: 03 weeks
Evaluation will be done using inch tape (inches) for Chest Expansion
Peak expiratory flow rate
Time frame: 03 weeks
Evaluation will be done by using Peak flow meter
Dyspnea
Time frame: 03 weeks
Evaluation will be done by using Modified Medical Research Council Dyspnea Scale (mMRC)
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 7 Oct 2025.
Related trials for Pulmonary Disease, Chronic Obstructive (COPD)
Active, not recruiting
Symptoms and Functions in Patients With COPD and Chronic Bronchitis Switching From CIG to THS
COPD, Smoking
Not yet recruitingPhase 2/3
An Open-Label Extension Study to Evaluate Inhaled Treprostinil SMI in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD)
Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease
Not yet recruiting
The Aim of the Study is to Decipher the Alterations in Signalling Pathways of Skeletal Muscle Stem Cells (Satellite Cells (SCs)) in Individuals With COPD, as Well as to Examine the Effect of Exercise Training on SCs.
COPD (Chronic Obstructive Pulmonary Disease), Sarcopenia in Elderly
Not yet recruitingPhase 2
Study of Treprostinil Administered Via Soft Mist Inhaler (SMI) in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD)
Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease
Active, not recruitingPhase 1
A Study for GSK3862995B in Healthy Participants and Participants With Chronic Obstructive Pulmonary Disease
Pulmonary Disease, Chronic Obstructive
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Pilates Breathing Technique along with standard pharmacological management and Pursed-lip breathing along with pharmacological management in people with Pulmonary Disease, Chronic Obstructive (COPD), run by Foundation University Islamabad at 1 site in Pakistan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 7 Oct 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Sana Kalim, DPT (03369169645, sanakalim408@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Chest Expansion (time frame: 03 weeks). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Oct 2025.